A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

NCT02147938 · clinicaltrials.gov ↗

COMPLETED

Status

578

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Tacrolimus

Sponsor

Astellas Pharma S.A.S.